The Latest Cardiac and Vascular News
MINNESOTA, United States–(BUSINESS WIRE)– Osprey Medical Inc.(ASX:OSP) today announced a multi-center observational study for the DyeVert Plus™ System will feature at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Session in April 2018. The abstract entitled: A Multi-Center Observational Study of the DyeVert Plus™ Contrast Reduction System summarizes a single-arm, multi-center observational […]
IRVINE, Calif., Feb. 15, 2018 /PRNewswire/ — Edwards Lifesciences(NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has received CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. The Edwards CENTERA […]
HeartFlow Completes Series E Financing, Securing $240 Million Proceeds Will Support Commercialization of HeartFlow® FFRct Analysis, Continued Technology Innovation and Additional Clinical Studies REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ramp up commercial […]
LivaNova to Acquire TandemLife Company will add advanced cardiopulmonary temporary support solutions to its portfolio LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions (“TandemLife”). The […]
Feb. 14, 2018 13:00 UTC 50 Premier U.S. Centers Adopt Sentinel Device in First Phase of Commercial Launch More Than 5,500 Patients Protected Worldwide Only Commercially Available TAVR Cerebral Protection Device in U.S., Europe and Asia Stacy Enxing Seng Joins Company’s Board of Directors SANTA ROSA, Calif.–(BUSINESS WIRE)– Since FDA […]
Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) — Abiomed(Nasdaq:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an expanded U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for the […]
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Feb 14, 2018 — Novoheart(“Novoheart” or the “Company”) (TSX VENTURE: NVH), through its wholly owned US subsidiary, has entered into a commercial agreement with Sumocor LLC(“Sumocor”), a biotech company based in New York City that is focused on the development of therapeutics for cardiovascular diseases. Pursuant to […]
Topline Results from First-in-Human Phase 1 Study of MYK-491 in Healthy Volunteers Demonstrated Tolerability and Increased Contractility SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) —MyoKardia (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that dosing has commenced in […]
DUBLIN–(BUSINESS WIRE)–The “Global Heart Valve Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to ResearchAndMarkets.com’s offering. The global heart valve devices market was valued at US$ 4,945 Mn in 2016, and is expected to reach US$ 13,377.9 Mn […]
VANCOUVER, Feb. 12, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that Fred Colen, President and Chief Executive Officer of Neovasc, is scheduled to present at the LEERINK Partners 7th Annual Global Healthcare Conference on Wednesday, February 14th at 2:30 pm ET at the Lotte New York Palace in New York City. A live […]
